Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 15/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | CA7 | P43166 | 2/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16706068 | 0.95 | TSHR (0.50) | ACACBCA12CA1CA2CA7 | |
| SCHEMBL12781078 | 0.92 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17975072 | 0.88 | L3MBTL1 (0.46) | CA12CA1CA2CA9L3MBTL1 | |
| SCHEMBL4872642 | 0.83 | ALDH1A1 (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL14560509 | 0.82 | PLA2G2A (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5584060 | 0.82 | S1PR1 (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5583900 | 0.81 | ALDH1A1 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3434851 | 0.81 | ACACB (0.57) | ACACBCA12CA1CA2CA7 | |
| SCHEMBL16706066 | 0.81 | ACACB (0.57) | ACACBCA12CA1CA2CA7 | |
| SCHEMBL17987958 | 0.78 | PTGDR2 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150132184-A1 | CHARGED SINGLET-OXYGEN SENSITIZERS AND OPPOSITELY-CHARGED SURFACTANTS | THE REGENTS OF THE UNIVERSITY OF NEW MEXICO | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150132184-A1 | CHARGED SINGLET-OXYGEN SENSITIZERS AND OPPOSITELY-CHARGED SURFACTANTS | SPTSSB, TST, DDT | ACACB 2117/4885CA12 2042/4885CA1 1617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.